DiaSys Diagnostic Systems GmbH

Booth number Hall 2 - 2.F30

www.diasys-diagnostics.com

For more than 30 years, DiaSys Diagnostic Systems GmbH is focused on developing, manufacturing and commercializing high quality system solutions for small up to medium sized labs.

About us

Diagnostic reagents and system solutions of outstanding quality!

DiaSys Diagnostic Systems GmbH is a leading specialist in development and manufacturing of diagnostic system solutions for more than 30 years. Our goal is to combine high quality with ease of use and to reduce the environmental burden.

Focusing on clinical chemistry and immunoturbidimetric tests, DiaSys has introduced more than 90 reagents in user-friendly kits for manual or automated use. DiaSys reagents ensure reliable results in routine and special diagnostics as e.g. diabetes, metabolic syndrome, lipid disorders, iron metabolism, pancreatic, kidney or liver diseases.

DiaSys has been an ISO-certified company (ISO 13485) since 1996. To date, customers and partners in more than 140 countries rely on DiaSys’ quality.

Address
DiaSys Diagnostic Systems GmbH
Alte Str. 9
65558 Holzheim
Germany

Phone: +49 6432 91460
Internet: www.diasys-diagnostics.com

Contact person

Christophe Bayet
General Manager Global Business / Head of Sales

Products and Services

Riele “Photometer 505"

The Riele “Photometer 505“ is a compact flow cell photometer. It is equipped with a superior 32 µL flow cell and offers a wide range of possible measurement methods and calculation options. Together with the high quality reagents from DiaSys and the preprogrammed applications, the photometer 505 is a solution for small laboratories or as a backup system for medium sized laboratories for precise and reliable patient results. It is equipped with 6 filters (340 nm – 623 nm) and an internal printer.

Further reading

respons® family

With throughputs starting from 100 tests/hour for respons®910 through respons®920 with 200 tests/hour up to 640 tests/hour incl. ISE measurements for respons®940, the fully automated respons® analyzers cover the requirements for small to medium laboratories. Together with DiaSys high-quality reagents, modern software features, pre-programmed CE-applications, carry over evasion lists and a uniform bottle concept, the respons® family delivers reliable results for a broad parameter portfolio.

Further reading

HDL-c direct FS and LDL-c direct FS

DiaSys has recently extended its cardiovascular risk assessment portfolio by two innovative new reagents, HDL-c direct FS and LDL-c direct FS. Both are homogenous assays for direct determination. The high quality reagents manufactured in Germany offer long calibration and onboard stability of up to 4 months. Combined with wide measuring ranges and good precision at clinical cut-off points, DiaSys assays HDL-c direct FS and LDL-c direct FS are of high value for clinical-chemistry laboratories.

Further reading

News & Innovations

Innovation prize for DiaSys and Fresenius University of Applied Sciences
The state Rhineland-Palatinate awards the 2021 Innovation Prize in the category “cooperation“ to DiaSys Diagnostic Systems GmbH along with Hochschule Fresenius, University of Applied Sciences, for developing a new procalcition test using PETIA technology.
The innovative reagent Procalcitonin FS, developed in cooperation with Hochschule Fresenius, is based on a further development of the PETIA technology. In contrast to conventionally complex determination methods in laboratory, no special equipment is needed for handling. The PETIA method may be applied to almost all available clinical chemistry analyzers worldwide. The test guarantees precise procalcitonin results while saving both cost and time and allows early diagnosis and immediate therapeutic measures. The excellent performance characteristics of Procalcitonin FS have been confirmed in renowned medical publications since its introduction; a patent has been filed for the innovative manufacturing process of Procalcitonin FS.
Further reading
New reagent for direct determination of LDL-cholesterol
LDL-c direct FS, a new homogeneous assay for the direct determination of LDL-cholesterol (LDL-C) is one of the latest products in the DiaSys portfolio. LDL-C is used as part of the lipid panel to estimate the risk of developing heart disease and to guide and monitor lipid-lowering therapies. Atherosclerotic cardiovascular disease starts early in life, often during childhood without symptoms and signs. Studies revealed that 71% and 43% of middle-aged men and women, respectively, show evidence of subclinical atherosclerosis. Evidence from epidemiologic, genetic, and clinical intervention studies have clearly demonstrated that low-density lipoprotein is causal in this process.
LDL-c direct FS is characterized by a wide measuring range and shows good overall precision at clinical cut-off points. The ready-to-use reagent may be applied on all automated clinical chemical analyzers and shows good comparability with commercially available methods for the determination of LDL-cholesterol.
Further reading
New reagent for determination of Lactate Dehydrogenase (LDH)
LDH 21 FS, a new assay for determination of Lactate Dehydrogenase (LDH) was launched in 2021. Increased LDH activities are found in a variety of pathological conditions such as myocardial infarction, liver diseases, blood diseases, and cancer or muscle diseases. Increased serum LDH values are also one of the abnormal diagnostic parameters in COVID-19 patients with a severe or fatal course of disease.
For LDH, a standardized reference method by IFCC is available. The new LDH 21 FS uses a modified IFCC method that shows optimized performance. An improved calibration and onboard stability, as well as a wide measuring range, high precision at clinical cut-offs and minimized interferences by common blood components, characterize the reagent.
The new test may be applied on all automated clinical chemical analyzers and shows good comparability with commercially available methods for the determination of LDH.
Further reading

Click here if you notice an image that violates copyright or privacy rights.

Get in contact
OK

We only use functionally necessary cookies and the web analysis tool Matomo in order to optimally design and continuously improve our website for you. By continuing to use our website, you agree to this. Further information and an objection possibility can be found here: Data protection